Genmedica Therapeutics SL - Company Review
Genmedica Therapeutics SL - Company ReviewSummary
Genmedica Therapeutics SL (Genmedica) is a clinical-stage biopharmaceutical company that researches, discovers and develops orally available NCEs for the treatment of diabetes. The company’s expertise spans in the development of specific, dual-action, small molecule inhibitors that targets both oxidative stress and inflammation pathways. Its portfolio of product pipeline includes GMC-252, GMC-316 and GMC-278. The company is funded by ICF Capital, Grupo Ferrer Internacional, Caixa Capital Risc, Uninvest, Cabrera Capital, Innova 31 and Venture Cap and others. It works as a quasi-virtual company with collaborative operations in Spain, the US, India, and the UK. Genmedica is headquartered in Barcelona, Spain.
This comprehensive company report of Genmedica Therapeutics SL provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.